MicroPort CardioFlow Medtech (HKG:2160) said it entered distribution agreements with its substantial shareholder MicroPort, according to a Hong Kong bourse filing Wednesday.
Shares of the medical device company were 3% lower in morning trade Thursday.
Under the agreements, MicroPort CardioFlow received non-exclusive rights to distribute certain products overseas.
The distribution frameworks will last until Dec. 31, 2028, the firm said.